Radiotherapy Reduces Atypical Meningioma Recurrence by Nearly Half, Lancet Study Finds

A new international phase 3 trial, ROAM/EORTC-1308, published in The Lancet, indicates that immediate radiotherapy following complete surgical removal of an atypical meningioma significantly reduces the risk of tumor recurrence by almost 50%. This research provides robust evidence to guide post-surgical treatment decisions for this type of brain tumor.